drugset / Trial / NCT04391478

Efficacy and Safety of Milrinone Versus Sildenafil in the Treatment of Neonates With Persistent Pulmonary Hypertension

NCT04391478

Phase 1 Completed 40 enrolled Rania Ali El-Farrash
RandomizedParallel-groupSingle-blindTreatment

Summary

Compare the effect of milrinone versus sildenafil in treatment of neonates with persistent pulmonary hypertension.

Timeline

Start
2015-01
Primary completion
2015-04
Completion
2015-09

Drugs

EvaluationDrugModalityDoseRoute
Comparator Milrinone Small molecule 0.25 mg/kg Intravenous
Comparator Milrinone Small molecule 0.75 mg/kg Intravenous
Comparator Sildenafil Unknown 0.2 mg/kg Other
Comparator Sildenafil Unknown 0.5 mg/kg Other